Logo image
Arteriovenous metabolomics in pigs reveals CFTR regulation of metabolism in multiple organs
Journal article   Open access   Peer reviewed

Arteriovenous metabolomics in pigs reveals CFTR regulation of metabolism in multiple organs

Hosung Bae, Bo Ram Kim, Sunhee Jung, Johnny Le, Dana M van der Heide, Wenjie Yu, Sang Hee Park, Brieanna M Hilkin, Nicholas D Gansemer, Linda S Powers, …
The Journal of clinical investigation, Vol.134(13), e174500
07/01/2024
DOI: 10.1172/JCI174500
PMCID: PMC11213515
PMID: 38743489
url
https://doi.org/10.1172/JCI174500View
Published (Version of record) Open Access

Abstract

Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene cause cystic fibrosis (CF), a multiorgan disease that exhibits diverse metabolic defects. However, other than specific CFTR mutations, the factors that influence disease progression and severity remain poorly understood. Aberrant metabolite levels have been reported, but whether CFTR loss itself or secondary abnormalities (infection, inflammation, malnutrition, and various treatments) drive metabolic defects are uncertain. Here, we implemented comprehensive arteriovenous metabolomics in newborn CF pigs, and the results revealed CFTR as a bona fide regulator of metabolism. CFTR loss impaired metabolite exchange across organs, including disrupted lung uptake of fatty acids yet enhanced uptake of arachidonic acid, a precursor of pro-inflammatory cytokines. CFTR loss also impaired kidney reabsorption of amino acids and lactate and abolished renal glucose homeostasis. These and additional unexpected metabolic defects prior to disease manifestations reveal a fundamental role for CFTR in controlling multi-organ metabolism. Such discovery informs a basic understanding of CF, provides a foundation for future investigation, and has implications for developing therapies targeting only a single tissue.

Details

Metrics

Logo image